• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺二氯二氨合铂(II)耐药的人肿瘤细胞系对PtCl4(Rh-123)2具有协同敏感性:线粒体参与的证据

cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.

作者信息

Ara G, Kusumoto T, Korbut T T, Cullere-Luengo F, Teicher B A

机构信息

Dana-Farber Cancer Institute, Boston, Massachusetts 02115.

出版信息

Cancer Res. 1994 Mar 15;54(6):1497-502.

PMID:8137254
Abstract

Three human tumor cell lines made resistant to cis-diamminedichloroplatinum(II) (CDDP), SCC-25/CP, MCF-7/CP, and C13, are more sensitive to rhodamine-123 [tetrachloroplatinum(II)] [(PtCl4(Rh-123)2] than are the corresponding parental cell lines. The CDDP-resistant cells have higher intracellular concentrations of PtCl4(Rh-123)2 for the same exposure than do the parent cells. Each of the CDDP-resistant cell lines has an increased level of cytochrome c oxidase activity compared with the parent cell lines, indicating that the resistant cells have greater mitochondrial mass or activity than the parent cells. In fact, there was a linear correlation between the increase in cytochrome c oxidase activity and the increased sensitivity to PtCl4(Rh-123)2 in the CDDP-resistant lines. Exposure of the cells to each of the mitochondrial effectors, chloramphenicol, FCCP, oligomycin, or antimycin prior to and during exposure to CDDP or PtCl4(Rh-123)2 had variable effects on the cytotoxicity of the platinum complexes in the parental lines. However, there was a consistent decrease in the cytotoxicity of PtCl4(Rh-123)2 in the CDDP-resistant cells in the presence of the mitochondrial effectors such that, in some cases, the CDDP-resistant lines were now less responsive to PtCl4(Rh-123)2 than were the parent cell lines. These studies indicate that mitochondrial alterations may be an important component of CDDP resistance in these cell lines and that PtCl4(Rh-123)2 may represent a prototype platinum complex useful in the treatment of CDDP resistant tumors.

摘要

三种对顺二氯二氨铂(II)(CDDP)产生抗性的人肿瘤细胞系,即SCC - 25/CP、MCF - 7/CP和C13,比相应的亲本细胞系对罗丹明 - 123 [四氯铂(II)] [(PtCl4(Rh - 123)2] 更敏感。在相同暴露条件下,CDDP抗性细胞内PtCl4(Rh - 123)2的浓度高于亲本细胞。与亲本细胞系相比,每个CDDP抗性细胞系的细胞色素c氧化酶活性水平都有所提高,这表明抗性细胞比亲本细胞具有更大的线粒体质量或活性。事实上,在CDDP抗性细胞系中,细胞色素c氧化酶活性的增加与对PtCl4(Rh - 123)2敏感性的增加之间存在线性关系。在暴露于CDDP或PtCl4(Rh - 123)2之前及期间,将细胞暴露于每种线粒体效应物,即氯霉素、FCCP、寡霉素或抗霉素,对亲本细胞系中铂配合物的细胞毒性有不同影响。然而,在存在线粒体效应物的情况下,CDDP抗性细胞中PtCl4(Rh - 123)2的细胞毒性持续降低,以至于在某些情况下,CDDP抗性细胞系对PtCl4(Rh - 123)2的反应性现在比亲本细胞系更低。这些研究表明,线粒体改变可能是这些细胞系中CDDP抗性的一个重要组成部分,并且PtCl4(Rh - 123)2可能代表一种可用于治疗CDDP抗性肿瘤的铂配合物原型。

相似文献

1
cis-Diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2: evidence for mitochondrial involvement.顺二氯二氨合铂(II)耐药的人肿瘤细胞系对PtCl4(Rh-123)2具有协同敏感性:线粒体参与的证据
Cancer Res. 1994 Mar 15;54(6):1497-502.
2
Effect of hyperthermia on cis-diamminedichloroplatinum(II) (rhodamine 123)2[tetrachloroplatinum(II)] in a human squamous cell carcinoma line and a cis-diamminedichloroplatinum(II)-resistant subline.热疗对人鳞状细胞癌系和顺二氯二氨铂(II)耐药亚系中顺二氯二氨铂(II)(罗丹明123)2[四氯铂(II)]的影响。
Cancer Res. 1988 Sep 15;48(18):5101-5.
3
Effect of hyperthermia on the action of cis-diamminedichloroplatinum(II), rhodamine 123(2) [tetrachloroplatinum(II)], rhodamine 123, and potassium tetrachloroplatinate in vitro and in vivo.热疗对顺二氯二氨铂(II)、若丹明123(2)[四氯铂(II)]、若丹明123及四氯铂酸钾体内外作用的影响。
Cancer Res. 1988 May 1;48(9):2335-41.
4
Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).一株对顺二氯二氨铂(II)耐药的人鳞状癌细胞系的特性分析
Cancer Res. 1987 Jan 15;47(2):388-93.
5
Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.氯尼达明作为一种体外和体内烷化剂活性调节剂。
Cancer Res. 1991 Feb 1;51(3):780-4.
6
Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.烷化剂:人类细胞系中交叉耐药模式的体外研究
Cancer Res. 1986 Sep;46(9):4379-83.
7
Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.细胞内谷胱甘肽与七种铂化合物的细胞毒性及耐药性的关系
Cancer Res. 1992 Dec 15;52(24):6885-9.
8
cis-diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines.
Cancer Res. 1988 Jun 15;48(12):3355-9.
9
Mitochondrial defects in cis-diamminedichloroplatinum(II)-resistant human ovarian carcinoma cells.顺二氯二氨合铂(II)耐药的人卵巢癌细胞中的线粒体缺陷
Cancer Res. 1992 Apr 1;52(7):1895-901.
10
In vitro cytotoxicity of a novel antitumor antibiotic, spicamycin derivative, in human lung cancer cell lines.一种新型抗肿瘤抗生素——螺旋霉素衍生物在人肺癌细胞系中的体外细胞毒性
Cancer Res. 1995 Mar 1;55(5):1075-9.

引用本文的文献

1
Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells.常见的生物学表型特征表征了上皮性卵巢癌细胞获得铂耐药性的过程。
Sci Rep. 2017 Aug 2;7(1):7104. doi: 10.1038/s41598-017-07005-1.
2
Solution behaviour and biological activity of bisamidine complexes of platinum(II).铂(II)双脒配合物的溶液行为和生物活性
J Biol Inorg Chem. 2007 May;12(4):477-93. doi: 10.1007/s00775-006-0202-x. Epub 2007 Jan 9.
3
Identification of genes differentially expressed in association with acquired cisplatin resistance.
与获得性顺铂耐药相关的差异表达基因的鉴定。
Br J Cancer. 2000 Oct;83(8):1047-54. doi: 10.1054/bjoc.2000.1420.